Literature DB >> 33245701

Immune Competence and Minimizing Susceptibility to COVID-19 and Other Immune System Threats.

Chris D Meletis, Kimberly Wilkes.   

Abstract

Exposure to viruses, bacteria, and other pathogens is unavoidable. Yet, the mere presence of these threats is not enough to automatically predispose to illness. The susceptibility of an individual to viral or bacterial infections is dependent upon immune competence. Many factors can interfere with the functioning of the immune system. Epigenetic alterations in the form of lifestyle or environmental factors can lead to impaired immunity. For example, exposure to air pollution can increase the risk of complications and mortality from COVID-19. Obesity can also exacerbate the damaging effects of air pollution on the lungs and may enhance the association between air pollution and increased COVID-19 severity. Poor sleep is another factor leading to impaired immunity, likely due to the coinciding melatonin depletion. Melatonin has been found to have antiviral and immune-enhancing effects, and it has been proposed that this hormone may be beneficial in COVID-19 patients. Zinc and vitamins D and C have also been well studied for their ability to shorten the duration of upper respiratory infections, and vitamin D has been found to reduce mortality in COVID-19 patients. Cannabidiol can both directly and indirectly improve immunity by enhancing natural killer cell activity, reducing inflammation, and relieving stress. Other dietary supplements backed by solid scientific evidence to show they act as immune enhancers are astragalus, a yeast fermentate (EpiCor®), olive leaf extract, berberine, N-acetyl cysteine, and garlic.

Entities:  

Mesh:

Year:  2020        PMID: 33245701

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  2 in total

1.  Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro.

Authors:  Yuan-Chieh Yeh; Ly Hien Doan; Zi-Yi Huang; Li-Wei Chu; Tzu-Hau Shi; Ying-Ray Lee; Cheng-Tao Wu; Chao-Hsiung Lin; Shu-Tuan Chiang; Hui-Kang Liu; Tsung-Hsien Chuang; Yueh-Hsin Ping; Hsiao-Sheng Liu; Chi-Ying F Huang
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

2.  Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19.

Authors:  Josef Finsterer; Fulvio A Scorza; Carla A Scorza; Ana C Fiorini
Journal:  World J Virol       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.